Miry Blich received her MD (1999) from the Ruth & Bruce Rappaport Faculty of Medicine, Technion-Israel Institute of Technology, Haifa, Israel. She completed three residencies at Rambam Health Care campus: internal medicine (2000–2004), cardiology (2004–2007), and electrophysiology (2007–2010). Dr Blich also completed a fellowship in inherited arrhythmia syndromes from Molecular Cardiology, IRCCS Fondazione Salvatore Maugeri, Pavia, Italy (2010-2011) and a fellowship in inherited cardiomyopathies in inherited cardiovascular disease unit, the heart hospital UCL, London, UK (2014). In 2011, Dr. Blich founded the Inherited Arrhythmia Clinic at Rambam— The clinic specialized in the diagnosis, treatment and long term follow up of patients with inherited cardiomyopathies and inherited channelopathies- two leading causes of heart failure and sudden cardiac arrest in the young. The clinic was the first in Israel to perform routine genetic testing for every patient who was suspected to have inherited heart disease and to use the genetic testing as a clinical routine tool for diagnosis, risk assessment and treatment selection in these challenging patients. The uniqueness of the clinic is this pioneering approach that combines comprehensive   cardiac evaluation and the genetic diagnosis. Today the clinic serves over 1800 patients from across Israel and is a national leader in its field. Since 2011 Miry Blich is a Senior Cardiologist in the Department of Cardiology and in the Electrophysiology Unit at Rambam, and is Head of the Inherited Arrhythmia Clinic and Women's Heart Clinic. In addition to her clinical work, Dr. Blich is involved in clinical and basis research. She has received several prizes, including the Neufeld Award for original research work from the Israel Heart Society in 2012, and has authored several scientific publications.

• Chief, Department of Cardiology, Hôpital Bichat, Paris, France.
• Vice President (Research) of the board of the Assistance Publique-Hôpitaux de Paris network (38 hospitals).
• Professor of Cardiology at Université Paris-Cité, Paris, France
• Chair of the FACT (French Alliance for cardiovascular Clinical Trials) academic research network.
• Chair of the French National University Council for Cardiology (Conseil National des Universités)
• Senior Professor (innovation chair) at Institut Universitaire de France, since 2022

Dr Steg has extensive experience as a clinical trialist in coronary artery disease and has authored more than 1 700 peer-reviewed articles. His H-Index is 149 and he has > 130 000 citations. He has been ”highly cited researcher” every year since 2014. He is Senior Associate Editor for Circulation.

Rodney Falk is the Founder and Emeritus Director of the Brigham and Women's Hospital Amyloidosis Program, and Associate Professor of Medicine at Harvard Medical School. Boston MA USA. He has been involved with treating patients with amyloidosis for over 40 years and was previously at Boston University where he was a Professor of Medicine and Associate Director of The Boston University Amyloidosis Program. Dr Falk is a senior author or co-author on over 250 peer publications and has lectured nationally and internationally on cardiac topics in general and amyloid heart disease in particular.

Peter has a PhD in computer science and an MD in interventional cardiology. He has been a professor at Stanford for 25 years. He has been on the founding team of 25 startups in healthcare, having transitioned 18 of those into an M&A or IPO process. In his core lab at Stanford, he has led or participated in over 175 clinical trials, published over 550 manuscripts, trained over 150 fellows in cardiology and/or engineering, and been an advisor to several healthcare strategics in the US and abroad. He is a co-founder of Triventures (225M) in both Tel Aviv and Palo Alto, focused on medtech, SaaS, and data-driven healthcare technologies.